DGS Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
VCM
VPM
DGS Capital Management's VRTX Position: Q1 2026 in Review
DGS Capital Management increased its Vertex Pharmaceuticals (VRTX) stake by 13% in Q1 2026, buying an estimated $69.5K and bringing the position to 1,310 shares worth $585K. The position accounts for 0.1% of the portfolio, ranked #205.
DGS Capital Management first reported a position in VRTX in Q1 2024 and has held it in 7 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- DGS Capital Management held 1,310 shares of Vertex Pharmaceuticals worth $585K as of Q1 2026.
- DGS Capital Management bought 149 Vertex Pharmaceuticals shares in Q1 2026, an estimated $69.5K.
- Vertex Pharmaceuticals made up 0.1% of DGS Capital Management's portfolio in Q1 2026, its #205 holding.
- DGS Capital Management first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 7 quarters since.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.